Related Experiment Video
Updated: Sep 30, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACs
Lisa J Alcock1, Yunchao Chang1, Jamie A Jarusiewicz2
1Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, United States.
Abstract:
Aberrant activation of the JAK-STAT signaling pathway has been implicated in the pathogenesis of a range of hematological malignancies and autoimmune disorders. Here we describe the design, synthesis, and characterization of JAK2/3 PROTACs utilizing a phenyl glutarimide (PG) ligand as the cereblon (CRBN) recruiter. SJ10542 displayed high selectivity over GSPT1 and other members of the JAK family and potency in patient-derived ALL cells containing both JAK2 fusions and CRLF2 rearrangements.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Protein Kinases and Phosphatases
TGF - β Signaling Pathway
MAPK Signaling Cascades

